All public logs
Jump to navigation
Jump to search
Combined display of all available logs of HemOnc.org - A Hematology Oncology Wiki. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).
(newest | oldest) View (newer 20 | older 20) (20 | 50 | 100 | 250 | 500)- 14:06, 28 February 2024 Jwarner talk contribs created page Category:Hemoglobin S polymerization inhibitors (Created page with "Category:Classical hematology medications")
- 13:08, 24 February 2024 Jwarner talk contribs created page Category:Antineoplastic bispecific antibodies (Created page with "Category:Targeted therapeutic Category:Bispecific antibody medications")
- 13:05, 24 February 2024 Jwarner talk contribs created page Category:Hematologic bispecific antibodies (Created page with "Category:Bispecific antibody medications")
- 13:04, 24 February 2024 Jwarner talk contribs created page Category:Immunostimulatory bispecific antibodies (Created page with "Category:Bispecific antibody medications")
- 12:35, 2 February 2024 Jwarner talk contribs moved page Momelotinib (CYT-387) to Momelotinib (Ojjaara) (FDA approval)
- 12:35, 2 February 2024 Jwarner talk contribs created page Category:EMA approved in 2024 (Created page with "Category:EMA approved drugs")
- 21:49, 23 January 2024 Jwarner talk contribs moved page Ovarian cancer, BRCA-mutated to Ovarian cancer, HRD-positive (Renaming to make the page more generic for HRD rather than just BRCA)
- 02:02, 20 January 2024 Jwarner talk contribs created page Category:Bcl-2 translation inhibitors (Created page with "Category:Apoptosis promoters")
- 02:02, 20 January 2024 Jwarner talk contribs created page Oblimersen (Genasense) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oblimersen-sodium NCI Drug Dictionary]: The sodium salt of a phosphorothioat...")
- 15:41, 19 January 2024 Jwarner talk contribs created page Category:Ornithine decarboxylase inhibitors (Created page with "Category:Enzyme inhibitors")
- 15:41, 19 January 2024 Jwarner talk contribs created page Eflornithine (Iwilfin) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eflornithine-hydrochloride NCI Drug Dictionary]: A difluoromethylated ornith...")
- 01:26, 19 January 2024 Jwarner talk contribs created page Category:Complement pathway inhibitors (Created page with "Category:Hematology medications")
- 01:25, 19 January 2024 Jwarner talk contribs created page Category:Complement factor D inhibitors (Created page with "Category:Complement pathway inhibitors")
- 01:24, 19 January 2024 Jwarner talk contribs created page Danicopan (ALXN-2040) (Created page with "==Mechanism of action== Complement factor D inhibitor ==Preliminary data== ===Paroxysmal nocturnal hemoglobinuria (PNH)=== #'''ALPHA:'...")
- 18:06, 18 January 2024 Jwarner talk contribs created page Category:Anti-DLL3-CD3 bispecific antibodies (Created page with "Category:Bispecific antibody medications")
- 18:05, 18 January 2024 Jwarner talk contribs created page Tarlatamab (AMG-757) (Created page with "==Mechanism of action== From the NCI Drug Dictionary: A bispecific T-cell engager (BiTE) antibody composed of two single-chain variable fragments (scFv), one directed against...")
- 12:18, 12 January 2024 Jwarner talk contribs created page Category:Cutaneous T-cell lymphoma medications (investigational) (Created page with "Category:Cutaneous T-cell lymphoma medications")
- 11:42, 6 January 2024 Jwarner talk contribs created page Category:Hepatic veno-occlusive disease medications (Created page with "Category:Supportive medications")
- 11:36, 6 January 2024 Jwarner talk contribs created page Category:Acute lymphoblastic leukemia medications (Created page with "Category:Leukemia medications")
- 11:36, 6 January 2024 Jwarner talk contribs created page Category:Acute lymphoblastic leukemia, infant medications (Created page with "Category:Acute lymphoblastic leukemia medications")